Your browser doesn't support javascript.
loading
Novel Proteome Targets Marking Insulin Resistance in Metabolic Syndrome.
Warmbrunn, Moritz V; Bahrar, Harsh; de Clercq, Nicolien C; Koopen, Annefleur M; de Groot, Pieter F; Rutten, Joost; Joosten, Leo A B; Kootte, Ruud S; Bouter, Kristien E C; Ter Horst, Kasper W; Hartstra, Annick V; Serlie, Mireille J; Soeters, Maarten R; van Raalte, Daniel H; Davids, Mark; Levin, Evgeni; Herrema, Hilde; Riksen, Niels P; Netea, Mihai G; Groen, Albert K; Nieuwdorp, Max.
Affiliation
  • Warmbrunn MV; Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • Bahrar H; Amsterdam UMC, Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • de Clercq NC; Amsterdam UMC, Cardiovascular Sciences, Amsterdam Cardiovascular Sciences, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • Koopen AM; Department of Internal Medicine, Radboud University Medical Center, 6525 EP Nijmegen, The Netherlands.
  • de Groot PF; Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • Rutten J; Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • Joosten LAB; Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • Kootte RS; Department of Internal Medicine, Radboud University Medical Center, 6525 EP Nijmegen, The Netherlands.
  • Bouter KEC; Department of Internal Medicine, Radboud University Medical Center, 6525 EP Nijmegen, The Netherlands.
  • Ter Horst KW; Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • Hartstra AV; Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • Serlie MJ; Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • Soeters MR; Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • van Raalte DH; Department of Endocrinology and Metabolism, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • Davids M; Department of Endocrinology and Metabolism, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • Levin E; Diabetes Center, Department of Endocrniology and Metabolism, Amsterdam UMC, VU University Medical Centers, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
  • Herrema H; Amsterdam Cardiovascular Sciences, VU University, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
  • Riksen NP; Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • Netea MG; Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • Groen AK; Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • Nieuwdorp M; Department of Internal Medicine, Radboud University Medical Center, 6525 EP Nijmegen, The Netherlands.
Nutrients ; 16(12)2024 Jun 10.
Article de En | MEDLINE | ID: mdl-38931177
ABSTRACT
CONTEXT/

OBJECTIVE:

In order to better understand which metabolic differences are related to insulin resistance in metabolic syndrome (MetSyn), we used hyperinsulinemic-euglycemic (HE) clamps in individuals with MetSyn and related peripheral insulin resistance to circulating biomarkers. DESIGN/

METHODS:

In this cross-sectional study, HE-clamps were performed in treatment-naive men (n = 97) with MetSyn. Subjects were defined as insulin-resistant based on the rate of disappearance (Rd). Machine learning models and conventional statistics were used to identify biomarkers of insulin resistance. Findings were replicated in a cohort with n = 282 obese men and women with (n = 156) and without (n = 126) MetSyn. In addition to this, the relation between biomarkers and adipose tissue was assessed by nuclear magnetic resonance imaging.

RESULTS:

Peripheral insulin resistance is marked by changes in proteins related to inflammatory processes such as IL-1 and TNF-receptor and superfamily members. These proteins can distinguish between insulin-resistant and insulin-sensitive individuals (AUC = 0.72 ± 0.10) with MetSyn. These proteins were also associated with IFG, liver fat (rho 0.36, p = 1.79 × 10-9) and visceral adipose tissue (rho = 0.35, p = 6.80 × 10-9). Interestingly, these proteins had the strongest association in the MetSyn subgroup compared to individuals without MetSyn.

CONCLUSIONS:

MetSyn associated with insulin resistance is characterized by protein changes related to body fat content, insulin signaling and pro-inflammatory processes. These findings provide novel targets for intervention studies and should be the focus of future in vitro and in vivo studies.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Insulinorésistance / Marqueurs biologiques / Protéome / Syndrome métabolique X Limites: Adult / Female / Humans / Male / Middle aged Langue: En Journal: Nutrients Année: 2024 Type de document: Article Pays d'affiliation: Pays-Bas

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Insulinorésistance / Marqueurs biologiques / Protéome / Syndrome métabolique X Limites: Adult / Female / Humans / Male / Middle aged Langue: En Journal: Nutrients Année: 2024 Type de document: Article Pays d'affiliation: Pays-Bas
...